Literature DB >> 21298503

Hemodiafiltration: the addition of convective flow to hemodialysis.

Michel Fischbach1, Helen Fothergill, Arianne Zaloszyc, Laure Seuge.   

Abstract

Hemodiafiltration (HDF) combines both hemofiltration (HF) and hemodialysis in the same procedure. It was initially performed in adults in 1977, and later used in children in the early 1980s. The use of HDF allows a determined convective dialysis dose to be combined with the conventional urea dialysis dose. The dialysis session is better tolerated as a result of the effects of hemofiltration. On-line HDF, i.e., substitution fluid prepared from ultrafiltration of the ultrapure dialysate, can be performed safely due to recent advances in modern technology. However, despite interest and feasibility in children, the majority of pediatric dialysis units across the world still perform hemodialysis using highly permeable membranes, allowing back filtration in the filter and therefore a degree of convective flow, i.e., internal hemodiafiltration. In some countries, government restrictions prohibit the use of on-line hemodiafiltration, (such as the FDA recommendations in North America), and therefore it should not be used in these circumstances.

Entities:  

Mesh:

Year:  2011        PMID: 21298503     DOI: 10.1007/s00467-011-1779-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  37 in total

1.  Do we need new indicators of dialysis adequacy based on middle-molecule removal?

Authors:  Raymond Vanholder; Sunny Eloot; Wim Van Biesen
Journal:  Nat Clin Pract Nephrol       Date:  2008-02-12

2.  Official recommendations for quality of fluids in dialysis -the need for standardisation.

Authors:  Rolf Nystrand
Journal:  J Ren Care       Date:  2009-06

Review 3.  Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.

Authors:  George Thomas; Bertrand L Jaber
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

4.  Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS.

Authors:  B Canaud; J L Bragg-Gresham; M R Marshall; S Desmeules; B W Gillespie; T Depner; P Klassen; F K Port
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

5.  Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.

Authors:  C Zehnder; J P Gutzwiller; K Renggli
Journal:  Clin Nephrol       Date:  1999-09       Impact factor: 0.975

6.  Adequacy of dialysis in children: does small solute clearance really matter?

Authors:  Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

7.  Reduction of hypotensive side effects during online-haemodiafiltration and low temperature haemodialysis.

Authors:  Johannes Donauer; Christoph Schweiger; Brigitta Rumberger; Bernd Krumme; Joachim Böhler
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

8.  Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate).

Authors:  M Fischbach; G Hamel; U Simeoni; J Geisert
Journal:  Nephron       Date:  1992       Impact factor: 2.847

9.  HDF promise for the future.

Authors:  Willy Lornoy; Johan De Meester
Journal:  Nephrol Dial Transplant       Date:  2008-05-21       Impact factor: 5.992

10.  Dialysis membrane: from convection to adsorption.

Authors:  Antonio Santoro; Gualtiero Guadagni
Journal:  NDT Plus       Date:  2010-05
View more
  8 in total

1.  Vancomycin pharmacokinetic model development in patients on intermittent online hemodiafiltration.

Authors:  Niels Westra; Johannes H Proost; Casper F M Franssen; Erik B Wilms; Marjolijn van Buren; Daan J Touw
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

2.  The interdialytic weight gain: a simple marker of left ventricular hypertrophy in children on chronic haemodialysis.

Authors:  Michael Fischbach; Ariane Zaloszyc; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2015-03-24       Impact factor: 3.714

Review 3.  Nocturnal intermittent hemodialysis.

Authors:  Julia Thumfart; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2014-08-08       Impact factor: 3.714

4.  Cystatin C in children on chronic hemodialysis.

Authors:  Olivera Marsenic; Andrea Wierenga; Donna R Wilson; Michael Anderson; Tripti Shrivastava; Garfield A Simon; Anne M Beck; Tiffany J Swanson; Kathleen Studnicka; Dorit Elberg; Kevin Couloures; Martin A Turman
Journal:  Pediatr Nephrol       Date:  2012-11-21       Impact factor: 3.714

5.  Optimal hemodialysis prescription: do children need more than a urea dialysis dose?

Authors:  Fischbach Michel; Zaloszyc Ariane; Schaefer Betti; Schmitt Claus Peter
Journal:  Int J Nephrol       Date:  2011-05-16

6.  Innovative strategy with potential to increase hemodialysis efficiency and safety.

Authors:  Hsiao-Chien Chen; Hsiu-Chen Lin; Hsi-Hsien Chen; Fu-Der Mai; Yu-Chuan Liu; Chun-Mao Lin; Chun-Chao Chang; Hui-Yen Tsai; Chih-Ping Yang
Journal:  Sci Rep       Date:  2014-03-21       Impact factor: 4.379

Review 7.  Management of pediatric dialysis and kidney transplant patients after natural or man-made disasters.

Authors:  Lale Sever; Gülseren Pehlivan; Nur Canpolat; Seha Saygılı; Ayşe Ağbaş; Ebru Demirgan; Jun Oh; Elena Levtchenko; Dymtro D Ivanov; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2022-10-04       Impact factor: 3.651

Review 8.  Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.